CD4 T-lymphocyte activation is associated with peak expiratory flow variability in childhood asthma

https://doi.org/10.1016/S0091-6749(96)80070-4Get rights and content

Background: Asthma has been recognized as a chronic inflammatory disorder of the airway. We have investigated the relationships among the activation markers on lymphocytes, eosinophils, their serum products in the peripheral blood, and the variability of airway obstruction in childhood asthma.

Methods: Twenty-two patients with atopic asthma (mean age, 12 years) were treated regularly and asked to measure their peak expiratory flow (PEF) twice daily for 7 days. Peripheral venous blood was obtained on day 8.

Results: The absolute counts of CD4 T lymphocytes expressing the activation marker CD25 in the peripheral blood on day 8 correlated significantly with the values of the coefficient of variation (CV) of both morning PEF (p<0.01) and night PEF (p<0.05) obtained over 7 days, but those of CD8+/CD25+ T lymphocytes, those of CD23+ B lymphocytes, and the serum concentrations of soluble CD25 did not. The absolute counts of peripheral blood eosinophils also demonstrated a significant correlation with the CV values of both morning PEF (p<0.01) and night PEF (p<0.05).

Conclusion: CD4 T-lymphocyte activation and increased counts of eosinophils in peripheral blood correlate with CV of PEF in patients with asthma, suggesting that CV of PEF is a good marker for assessing not only the variability of airway obstruction but also the degree of airway inflammation

References (22)

  • KayAB

    Asthma and inflammation

    J Allergy Clin Immunol

    (1991)
  • GernJE et al.

    Peak flow variation in childhood asthma: a three-year analysis

    J Allergy Clin Immunol

    (1994)
  • SullivanP et al.

    Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

    Lancet

    (1994)
  • JefferyPK et al.

    Bronchial biopsy in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity

    Am Rev Respir Dis

    (1989)
  • AzzawiM et al.

    Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma

    Am Rev Respir Dis

    (1990)
  • LopezAF et al.

    Recombinant human interleukin-5 is a selective activater of human eosinophil function

    J Exp Med

    (1988)
  • HamidQ et al.

    Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma

    J Clin Invest

    (1991)
  • RobinsonDS et al.

    Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

    N Engl J Med

    (1992)
  • CherwinskiHM et al.

    Two types of mouse helper T cell clone III. Further difference in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies

    J Exp Med

    (1987)
  • CorriganCJ et al.

    CD4 T-lymphocyte activation in asthma is accopanied by increased serum concentration of interleukin-5. Effect of glucocorticoid therapy

    Am Rev Respir Dis

    (1993)
  • DoiS et al.

    Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbation of asthma: effect of glucocorticoid therapy

    Clin Exp Allergy

    (1994)
  • Cited by (0)

    View full text